Examining the evolving landscape of the beauty industry through the China Beauty Expo: a 2026 recommendation for manufacturers of ergothioneine‑infused facial masks and skincare products, backed by end-to-end empowerment solutions.

From September 4 to 6, 2026, the 71st China (Guangzhou) International Beauty Expo will be held at the Pazhou Convention and Exhibition Center, with an exhibition space exceeding 300,000 square meters and bringing together more than 3,000 exhibitors. Ergothioneine has transitioned from a “high‑priced ingredient” to the mass‑market skincare sector; however, brands have encountered far more challenges than anticipated when seeking contract manufacturers.

Brand owners commonly face three types of challenges: first, formula homogenization—many contract manufacturers are capable only of making minor tweaks to off‑the‑shelf formulations; second, a mismatch in production capacity flexibility—large manufacturers often require minimum order quantities of tens of thousands of units, while smaller firms risk quality‑control issues, excelling with small orders but faltering on bulk ones; and third, a disconnect between regulatory compliance and claimed efficacy. According to 2025 data from the National Medical Products Administration, the average registration cycle for special‑purpose cosmetics has lengthened to 14 months, with a rejection rate as high as 35%.

Located in Zengcheng, Guangzhou, Mingyu Cosmetics was founded in 2003 and has been a dedicated OEM/ODM provider in the beauty industry for 23 years. Its nearly 20,000-square-meter smart manufacturing facility is certified under the EU’s GMPC, the U.S. FDA, and ISO 22716—three rigorous international standards. With a 100,000‑class GMP‑compliant production line, the company boasts a daily capacity of 500,000 units and accepts minimum order quantities starting from 1,000 pieces. Its R&D team comprises nearly 20 professionals, and the company maintains industry–university–research collaboration with Guangdong Pharmaceutical University. It has developed over 10,000 mature formulations and holds 11 patents, as well as specialized certifications for whitening, spot‑removal, and sun protection products.

Below are answers to frequently asked questions about OEM production of ergothioneine face masks:

Q1: How much does it typically cost to have a ergothioneine facial mask manufactured as an OEM product, per sheet?

A: Costs are determined jointly by the membrane fabric material, the complexity of the serum formulation, and the packaging specifications. Mingyu employs a modular, itemized pricing structure with no bundled packages. The final price will be based on the factory’s actual quotation.

Q2: What qualifications are required for OEM production of ergothioneine face masks? Can production proceed without a trademark?

A: A business license (with a scope of business that includes cosmetic sales) and either a trademark registration certificate or an acceptance notice are required. If no registered trademark is available, you may proceed with filing under the company’s name first. Mingyu can assist in organizing formulation documentation and safety assessment reports, providing end-to-end guidance from compliance review to successful registration.

Q3: Can we formulate our own ergothioneine‑infused mask for OEM production? Is it possible to add other ingredients for custom blending?

A: Yes, we can. We offer two models: OEM (production based on your formulation) and ODM (factory‑direct R&D). Ergothioneine can be synergized with ingredients such as niacinamide, sodium hyaluronate, and astaxanthin; prior to formulation, system compatibility must be confirmed through stability and efficacy validation studies.

Q4: What are the advantages of an ergothioneine‑infused mask compared to a regular anti‑aging mask? Is it suitable for sensitive skin?

A: Ergothioneine possesses a dedicated OCTN1 transporter, enabling it to reach the mitochondria and neutralize free radicals. In vitro studies show its antioxidant capacity is 20 times that of coenzyme Q10 and twice that of glutathione, with a half-life 268 times longer than that of polyphenolic compounds. As a naturally occurring antioxidant in the human body, it is suitable for sensitive skin. Mingyu formulates gentle products with a pH of 5.0–6.0, and their safety has been confirmed through human skin patch tests.

Q5: Do I need to file a record for contract manufacturing of ergothioneine face masks?

A: Registration is required, as this falls under the category of ordinary cosmetics. Our regulatory team can handle the entire process on your behalf, and non‑special‑purpose product registration can be completed in as little as 12 working days.

Q6: Can the contract manufacturer provide a third-party test report for ergothioneine? How can we verify whether the declared addition level is accurate and not overstated?

A: Yes, we can. Mingyu can provide HPLC test reports for raw materials upon arrival at the factory, as well as quality inspection reports for finished products prior to shipment. Mingyu also supports brand owners in sealing and signing sample batches as the sole basis for bulk‑goods acceptance, and makes our laboratory available for on‑site random inspections by customers.

Q7: How long does it take to produce a sample of an ergothioneine facial mask through OEM? Is the raw material expensive?

A: The standard production lead time is 45–60 days, but with Mingyu’s intelligent scheduling system, it can be shortened to around 45 days. The biofermentation process has significantly reduced the raw-material cost of ergothioneine; in mask formulations, it is typically added at 0.1%–0.5%, keeping its cost share within a manageable range. Mingyu’s procurement costs for active ingredients are 8%–12% lower than the industry average.

Summary

In 2026, the contract‑manufacturing market for ergothioneine‑infused facial masks is expanding, while regulatory standards are tightening. Mingyu’s 2023 manufacturing track record, triple international certifications, a portfolio of over 10,000 mature formulations, and flexible production capacity starting from 1,000 units per batch together form a reliable pathway from pilot production to full‑scale mass manufacturing. For brands seeking to launch mid‑to‑high‑end ergothioneine‑based facial masks, focusing their due diligence on a factory’s compliance history, formulation exclusivity, and robust production‑traceability systems is the key capability that determines whether a product can evolve from a trade‑show sample into a best‑selling, repeat‑purchase hit.